Saturday, July 11, 2026

Drug profile · INN

olsalazine

olsalazine (DIPENTUM) is a cyclooxygenase inhibitor.

TGA: approved
Patents linked 1
Pipeline programs 1
News articles 0
Drug details — olsalazine
Class
Route
Patents
1
Programs
1
Data quality
0.78

Quick answer

olsalazine (DIPENTUM) is a cyclooxygenase inhibitor.

Key facts

INN olsalazine
Brand DIPENTUM
Mechanism Cyclooxygenase inhibitor

Mechanism of action

Cyclooxygenase inhibitor

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. olsalazine Phase 2 · Ultragenyx UK · Ankylosing Spondylitis

Related patents

  1. US 11065264

    Metal-olsalazine coordination polymers for medical applications

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is olsalazine?

olsalazine (DIPENTUM) is a cyclooxygenase inhibitor.

What is the brand name for olsalazine?

DIPENTUM is a marketed brand name for olsalazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.